Agenus reported $-49235000 in Pre-Tax Profit for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Pre Tax Profit Change
Agenus AGEN:US $ -49.24M 1.37M
AstraZeneca AZN:LN 258259.83M 36783.7M
Celldex Therapeutics CLDX:US $ -36M 12.95M
Chemocentryx CCXI:US $ -31.65M 6.96M
Dynavax Technologies DVAX:US $ 129.37M 96.52M
Genocea Biosciences GNCA:US $ -15.98M 2.7M
Immunogen IMGN:US $ -62.02M 37.88M
Intrexon XON:US $ -26.15M 6.84M
Karyopharm Therapeutics KPTI:US $ -48941000 7.67M
Macrogenics MGNX:US $ -41.3M 25.14M
Novartis NOVN:VX SF 4129M 217M
Novavax NVAX:US $ -509.07M 715.14M
Rigel Pharmaceuticals RIGL:US $ -13.49M 13.95M
Sangamo Biosciences SGMO:US $ -43.09M 0.83M
Veracyte VCYT:US $ -9.65M 4.82M